Industry Focus Transcripts

A look at the huge key differences between the Democratic and Republican energy platforms.

An EpiPen pricing debacle, an unexpected FDA rejection, and a sticker-shock inspiring M&A deal led to wild moves in Mylan N.V., Portola Pharmaceuticals, and Medivation shares this week.

Driverless car technology will be available to any automaker that wants it by 2019. Here’s what investors need to know.

First, it was Pixar, then Marvel and Lucasfilm -- now BAMTech appears to be the next major contribution to the future of the company.

Following last week's survey of the payment landscape on the financials show, two Fools do a deep dive into payments and services company Square.

Why Aetna is joining the ranks of commercial healthcare companies that are opting out of the Obamacare exchanges.

Industry Focus takes a dive into Trump’s energy platform, and what it’ll mean for the sector (and the world) if they go through.

Department store investors must be smiling, as four leading names in the industry have enjoyed 20% share price gains since reporting their second-quarter results.

Silver Wheaton’s unique strategy for success, and why it's doing so well recently.

Why the Permian has had such a pull for the past few years, and oil producers are itching to dig into it.

Every month trillions of dollars of transactions move around digital networks between consumers, merchants, and banks. Payment processors are the companies that make all that commerce possible, and in 2016, the business of payment processing is good.

Several key execs have stepped down from their posts at Alphabet subsidiaries in the past few months. On this episode, we explain why investors shouldn't worry too much.

Two Motley Fool analysts take a look at EOG Resources’ quarterly earnings, and why the company is so confident about $50 oil on the horizon.

A surprisingly happy success story from the energy industry’s recent past -- Parsley Energy’s new billionaire founder.

Earnings season is upon us, and some of the oil and gas industry’s top names are announcing plans to increase production in spite of stubbornly low oil prices.

Bristol-Myers Squibb's Opdivo came up short in a key lung cancer trial, causing shares to plummet. Should investors panic?

The bricks and mortar retail leader has bought an upstart digital player while Time Warner has invested in a service it has been critical of.

Chris Hill joins the podcast to talk about HBO's Silicon Valley and the different aspects of the tech start-up world it explores.

If you thought earnings season was coming to a close, think again. Earnings season for high-yield business development companies is just beginning.

The doctors on TV make it look like curing disease is simple and that the medicine is exciting, but the reality is far different from what we see in prime-time hospital dramas.